JP Patent

JP7436524B2 — ハンチントン病及びその症状を治療するためのプリドピジン及びその類似体を含む組成物

Assigned to プリレニア ニューロセラピューティクス リミテッド · Expires 2024-02-21 · 2y expired

What this patent protects

Patent listed against deuruxolitinib-phosphate.

Drugs covered by this patent

Patent Metadata

Patent number
JP7436524B2
Jurisdiction
JP
Classification
—
Expires
2024-02-21
Drug substance claim
No
Drug product claim
No
Assignee
プリレニア ニューロセラピューティクス リミテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.